Leukaemia

General overview of blood cancers.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
HaematologyOncology

Clinical Guidelines

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines
National
Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for
National
CKS: Haematological cancers - recognition and referral
National
ESMO Clinical Practice Guideline: Acute Myeloid Leukaemia
National
NICE guideline [NG47]
National
NICE guideline [TA408]: Pegaspargase for treating acute lymphoblastic leukaemia
National
NICE guideline [TA526]: Arsenic trioxide for treating acute promyelocytic leukaemia
National
NICE guideline [TA931]: Zanubrutinib for treating chronic lymphocytic leukaemia
National
2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia
Local
ACUTE LYMPHOBLASTIC LEUKAEMIA BEST PRACTICE GUIDELINES (2011) V1.00
Local
Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines
Local
Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®) - Health Professional Version
Local
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Local
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Local
Consensus guidelines for the diagnosis and management of hairy cell leukaemia
Local
Diagnosis and management of AML in adults: 2022 update
Local
ESMO Clinical Practice Guideline interim update on new targeted therapies in acute myeloid leukaemia
Local
ESMO Clinical Practice Guidelines: Haematological Malignancies
Local
Guidelines from the 2017 European Conference on Infections in Leukaemia
Local
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
Local
Primary antifungal prophylaxis in hematological malignancies: 2025 ECIL guidelines
Local